chemistry Archives
Vanderbilt-led team to develop ‘microbrain’ to improve drug testing
Jul. 24, 2012—Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process.
Insights for neuroscience drug discovery
Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
Probing the roots of depression by tracking serotonin regulation at a new level
Jun. 27, 2012—An interdisciplinary team of scientists have successfully tagged a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of individual molecules for the first time. This capability makes it possible to study the manner in which serotonin regulates mood, appetite and sleep at a new level of detail.
DNA: From modification to mutation
Jun. 8, 2012—Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.
Neuronal clues to cholesterol-defect disorder
Apr. 20, 2012—Antioxidants may be a beneficial treatment for an inherited genetic disorder.
Fungus toxin gets in the way in DNA
Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.
Vanderbilt University honors top students during Commencement
May. 13, 2011—Chancellor Nicholas S. Zeppos presented the Founder’s Medals to the top scholars from Vanderbilt University’s undergraduate and professional schools during Commencement on Friday, May 13.
Grant bolsters molecular imaging resource
Apr. 1, 2011—Vanderbilt has received a $10.3 million federal grant to establish a national research resource for mass spectometry.
Neuroscience drug discovery center opens at Vanderbilt
Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.
